Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

17.71
Delayed Data
As of 4:02pm ET
 +0.17 / +0.97%
Today’s Change
8.31
Today|||52-Week Range
32.74
+21.97%
Year-to-Date
TB Alternative Assets Ltd. Buys JD.com Inc, Ctrip. ...
Jul 20 / GuruFocus News - Paid Partner Content
4 Sell-Ranked Drug Stocks to Avoid Ahead of Q2 Earnings
Jul 17 / Zacks.com - Paid Partner Content
Valeant (VRX) To Sell Obagi for $190 Million to Lower Debt
Jul 19 / Zacks.com - Paid Partner Content
Allergan Reports Positive New Data on Irritable Bowl Drug
Jul 11 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, Flexion The...
Jul 18 / Zacks.com - Paid Partner Content